Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: March 2012

S&W Seed Company (SANW) to Present at the ROTH Capital Partners 24th Annual Conference

S&W Seed produces warm climate, high-yield alfalfa seed varieties, including varieties that can thrive in poor, saline soils. S&W Seed also offers seed cleaning and processing at its 40-acre facility in Five Points, Calif. S&W Seed recently began the commercial … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Questcor Pharmaceuticals, Inc. (QCOR) to Present at the ROTH Capital Partners 24th Annual Conference

Questcor Pharmaceuticals is a biopharmaceutical company focused on developing products to help patients with serious, difficult-to-treat medical conditions. Questcor’s specific areas of focus are in the fields of neurology and nephrology. The company is currently supporting research efforts in a … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Paramount Gold and Silver Corp. (PZG) to Present at the ROTH Capital Partners 24th Annual Conference

Paramount Gold and Silver is an exploration and development company with multi-million ounce advanced stage precious metals projects in Nevada  and northern Mexico. Paramount’s fully funded exploration programs are now in progress at these two core projects. The company has … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

NetSpend Holdings, Inc. (NTSP) to Present at the ROTH Capital Partners 24th Annual Conference

NetSpend Holdings provides general-purpose reloadable (GPR) prepaid debit cards and related financial services to consumers in the United States who do not have a traditional bank account or who rely on alternative financial services. NetSpend’s mission is to develop products … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Market Leader, Inc. (LEDR) to Present at the ROTH Capital Partners 24th Annual Conference

Market Leader provides online technology and marketing solutions for real estate professionals across the United States and Canada. Market Leader’s solutions are applicable to real estate agents, brokerages, and franchisors seeking solutions to grow and manage their businesses. Market Leader’s … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Iteris, Inc. (ITI) to Present at the ROTH Capital Partners 24th Annual Conference

Iteris focuses on the development and application of advanced technologies designed to reduce traffic congestion, minimize the environmental impact of traffic congestion, and improve the safety of surface transportation systems infrastructure. Iteris combines outdoor image processing, traffic engineering, and information … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Ironclad Performance Wear Corp. (ICPW) to Present at the ROTH Capital Partners 24th Annual Conference

Ironclad Performance Wear designs, develops, and distributes specialized task-specific gloves for industries such as oil & gas extraction; automotive; and police, fire, first-responder, and military. Ironclad’s gloves and apparel are available through industrial suppliers, hardware stores, home centers, lumber yards, … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

IRIDEX Corp. (IRIX) to Present at the ROTH Capital Partners 24th Annual Conference

IRIDEX develops, manufactures, and markets innovative and versatile laser-based medical systems, delivery devices, and consumable instrumentation for the ophthalmology and otolaryngology market. IRIDEX offers a suite of comprehensive technical, clinical, and service support programs. The company’s products are sold in … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

IntelliCell BioSciences, Inc. (SVFC) to Present at the ROTH Capital Partners 24th Annual Conference

IntelliCell BioSciences, a regenerative medicine company, is focused on the expanding regenerative medical markets using stromal vascular fraction derived from adult adipose tissue. IntelliCell will initially focus on selling laboratory suites and licensing its technology to doctors for use in … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

ImmunoCellular Therapeutics Ltd. (IMUC) to Present at the ROTH Capital Partners 24th Annual Conference

ImmunoCellular Therapeutics is a clinical-stage company developing immune-based therapies designed to improve the diagnosis and the treatment of brain and other cancers with high unmet medical needs. ImmunoCellular’s lead product candidate ICT-107 is in a phase II trial as a … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment